News Search Results
Feb 03, 2025, 17:30 ET SK Telecom Joins MIT GenAI Impact Consortium
AI, we will broaden our scope to encompass next-generation research areas and to convergent Vertical AI such as physical AI, manufacturing, and biotechnology." About SK Telecom SK Telecom has been leading the growth of the mobile industry since 1984. Now, it is taking customer experience
More news about: SK Telecom
Feb 03, 2025, 15:27 ET Breakthrough Properties Acquires MUSE, a Three-Building Trophy Life Science Campus in San Diego
and support scientific innovation across biotechnology, agriculture, and nutrition. Breakthrough combines Tishman Speyer's decades of global real estate development experience with Bellco Capital's industry-making biotechnology entrepreneurship to reimagine environments
More news about: Breakthrough Properties
Feb 03, 2025, 13:19 ET Rubin and Rudman Partner Glenn Wood Named to 2025 Lawdragon 500 Leading Environmental Lawyers
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Feb 03, 2025, 12:30 ET Tom Snipes to Lead Ostara as Chief Executive Officer
Board of Directors. Snipes most recently served as CEO of Custom Agronomics and also served as CEO of Plant Response Inc., a global plant biotechnology company specializing in nutrient use efficiency, plant innate immunity and plant physiology. Under his leadership, Plant Response successfully completed
More news about: Ostara
Feb 03, 2025, 11:09 ET Preclinical Imaging Market to Reach $3.02 Billion by 2030 | Rising Demand for Advanced Imaging in Drug Development - Valuates Reports
high-quality imaging systems. The Asia-Pacific region is rapidly emerging due to growing investments in biotechnology and increased focus on translational research in countries like China, Japan,
More news about: Valuates Reports
Feb 03, 2025, 10:25 ET Fisherman, Researcher, Friend: One Man's Selfless Commitment to Marine Science
to Gloucester, MA's historic waterfront, GMGI is catalyzing the regional economy. GMGI also runs the Gloucester Biotechnology Academy, a 10-month certificate training program to train recent high school graduates for careers as lab technicians. GMGI's state-of-the-art research
More news about: Gloucester Marine Genomics Institute
Feb 03, 2025, 09:30 ET K18 Launches Extreme Hair Rescue: A Celebration of Stylists and Community Healing Through Hair
professional stylists tackle the most challenging cases of hair damage, proving that no hair is beyond rescue when armed with K18's groundbreaking biotechnology.
More news about: K18 Biomimetic Hairscience
Feb 03, 2025, 09:00 ET Vetigenics secures $6 million seed financing, sees meaningful clinical progress
PHILADELPHIA, Feb. 3, 2025 /PRNewswire/ -- Vetigenics, a clinical-stage animal health biotechnology company specializing in antibody therapeutics for pets, announces significant progress over the past year, including closing a $6
More news about: Vetigenics
Feb 03, 2025, 09:00 ET Thryv Therapeutics to Participate in the 2025 Leerink Partners Global Healthcare Conference in Miami, FL
MONTREAL, Feb. 3, 2025 /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel therapies for cardiovascular diseases, is pleased to announce its participation in the 2025 Leerink Partners Global Healthcare
More news about: Thryv Therapeutics Inc.
Feb 03, 2025, 09:00 ET HoneyNaps' AI-Powered Sleep Diagnostic Software Designated as 73rd and 74th Innovative Medical Device by South Korea's Ministry of Food and Drug Safety
Devices? Innovative medical devices are advanced technologies integrating high-intensity innovations in fields such as information technology, biotechnology, and robotics. These devices offer significantly enhanced safety and efficacy compared to conventional products. The MFDS designates innovative
More news about: HoneyNaps
Feb 03, 2025, 08:30 ET CHEERS TO SIX YEARS! JUNIPR PUBLIC RELATIONS MARKS MORE THAN HALF A DECADE IN BUSINESS DOING SMART WORK FOR NICE PEOPLE™
Philadelphia, is proud to enter its sixth year of Doing Smart Work for Nice People™. Working in both B2B and B2C alike, with clients ranging from global biotechnology leaders to Chicago-area restaurants, household name CPG brands to regional medical practices, the company's comprehensive
More news about: Junipr Public Relations
Feb 03, 2025, 08:30 ET AlphaSense Continues to Redefine Healthcare Industry Insights with Unmatched AI-Driven Market Intelligence
AlphaSense has become an indispensable tool in healthcare—serving more than 80% of the top 50 global healthcare companies across pharmaceuticals, biotechnology, and healthcare investment—the platform's impact extends well beyond healthcare. Industries ranging from technology to finance, energy, and consumer
More news about: AlphaSense
Feb 03, 2025, 08:30 ET PhaseV and Alimentiv Partner on Machine Learning-Based Solution to Tackle Challenges in GI Clinical Trials
research since 1986. As a global CRO offering clinical, medical imaging and precision medicine services, Alimentiv partners with pharmaceutical and biotechnology industries to advance the development of novel therapies and accelerate their time to market. Alimentiv is headquartered in London,
More news about: PhaseV; Alimentiv Inc.
Feb 03, 2025, 07:30 ET CHMP Issues Positive Opinion for Subcutaneous RYBREVANT®(amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer
in nine commercialized products across more than 100 global markets, Halozyme has licensed its ENHANZE® technology to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical and
More news about: Halozyme Therapeutics, Inc.
Feb 03, 2025, 07:30 ET Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist
www.vandapharma.com and follow us on X @vandapharma. About Anaptys Anaptys is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics for autoimmune and inflammatory diseases. Its lead program, rosnilimab, a depleter
More news about: Vanda Pharmaceuticals Inc.
Feb 03, 2025, 07:00 ET Nona Biosciences Announces Strategic Collaboration with Invetx for Next-Generation Animal Health Biotherapeutics Discovery
Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced today that it has entered into a strategic collaboration with Invetx, Inc. ("Invetx"), a Boston-based animal biotechnology company, to develop
More news about: Nona Biosciences
Jan 31, 2025, 20:44 ET Biotech Market to Grow by USD 805.6 Billion (2025-2029), Boosted by Vendor Innovation, with AI Driving Market Transformation - Technavio
Therapeutics1.3 Diagnostics1.4 Industrial biotechnology1.5 OthersType 2.1 Red biotechnology2.2 White biotechnology2.3 Green biotechnology2.4 Grey biotechnology2.5 OthersGeography
More news about: Technavio
Jan 31, 2025, 20:22 ET High Throughput Screening (HTS) Market to Grow by USD 19.9 Billion (2024-2028), Boosted by Rising R&D Investments, with AI Redefining Market Landscape - Technavio
existing drugs for new indications. With advancements in technology, HTS is becoming more accessible to a wider range of organizations, including biotechnology startups and clinical trials. Despite these advancements, challenges remain, including false-positive findings and the need for specialized equipment
More news about: Technavio
Jan 31, 2025, 18:30 ET AMGEN ANNOUNCES WEBCAST OF 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing
More news about: Amgen
Jan 31, 2025, 10:01 ET Human Organs-on-Chips Market to Reach USD 1019 Million by 2031 | 31.2% CAGR Growth Forecast - Valuates Reports
efficiency of liver-on-a-chip models drive their widespread adoption in pharmaceutical and biotechnology sectors, fueling the growth of the Human Organs-on-Chips Market. Pharmaceutical and biotechnology companies play a pivotal role in driving the growth of the Human Organs-on-Chips Market
More news about: Valuates Reports
Jan 31, 2025, 07:30 ET Kadimastem Shareholders Approved the Merger with NLS Pharmaceutics
approved the merger with NLS (the "Merger"). This key milestone brings NLS and Kadimastem one step closer to creating a combined Nasdaq-traded biotechnology company with a robust portfolio of advanced therapies for neurodegenerative diseases and diabetes.
More news about: NLS Pharmaceutics Ltd.; Kadimastem Ltd.
Jan 31, 2025, 07:30 ET Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline
registered trademarks of Bellus Medical, LLC and StriVectin Operating Company, Inc., respectively. About Revance Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that enhance patient outcomes and physician experiences.
More news about: Crown Laboratories, Inc.
Jan 31, 2025, 07:19 ET Data Vault Holdings Inc. Rebrands as EOS Technology Holdings Inc., Ushering in a New Dawn of Innovation
commitment to leveraging its deep expertise and intellectual property portfolio to propel advancements in aerospace robotics, blockchain-gaming, and biotechnology through its new operating divisions: EOS Aerospace™ and EOS Earth™. EOS Aerospace: Significant Opportunities in the Galactic
More news about: EOS Technology Holdings Inc.
Jan 31, 2025, 00:13 ET Vaccine Research Market to Grow by USD 21.4 Billion (2024-2028), High Prevalence of Infectious Diseases Boosting the Market, with AI Impacting Market Trends - Technavio
government announced an additional USD31.9 billion investment. India's Department of Biotechnology (DBT) also supports vaccine R and D through initiatives like the Indo-US Vaccine Action Program (VAP), Mission COVID Suraksha, Ind-CEPI Mission,
More news about: Technavio
Jan 30, 2025, 16:44 ET FAST-AFFILIATED RESEARCH PROGRAM AT UCLA IS AWARDED $5.8M TO ADVANCE GENE THERAPY FOR ANGELMAN SYNDROME
gene that is generally either missing or not functioning in patients living with AS. The data to date, funded by TransformaTx Biotherapeutics, a biotechnology company founded by the
More news about: Foundation for Angelman Syndrome Therapeutics (FAST)